Cargando…

Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada

BACKGROUND: A cost-minimization analysis (CMA) was performed to evaluate the economic implications of introducing the SQ Tree sublingual immunotherapy (SLIT)-tablets marketed as ITULATEK® (Health Canada regulatory approval in April 2020) for the treatment of pollen-induced (birch, alder and/or hazel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellis, Anne K., Gagnon, Rémi, Hammerby, Eva, Shen, Julia, Gosain, Sheena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264484/ https://www.ncbi.nlm.nih.gov/pubmed/34238358 http://dx.doi.org/10.1186/s13223-021-00565-y

Ejemplares similares

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
por: Ueda, Shoko, et al.
Publicado: (2022)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
por: Lou, Hongfei, et al.
Publicado: (2020)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
por: Massaro, Ilaria, et al.
Publicado: (2017)

Pollen-related food allergy in children with seasonal allergic rhinitis
por: Cudowska, Beata, et al.
Publicado: (2021)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials
por: Li, Yi, et al.
Publicado: (2018)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
por: Horak, F, et al.
Publicado: (2009)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Cognitive dysfunction and quality of life during pollen season in children with seasonal allergic rhinitis
por: Papapostolou, Georgia, et al.
Publicado: (2020)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
por: Tankersley, Mike, et al.
Publicado: (2021)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
por: Wang, Jiarong, et al.
Publicado: (2021)

5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study
por: Pastorello, Elide Anna, et al.
Publicado: (2013)

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

The Effect of Broccoli Sprout Extract on Seasonal Grass Pollen-Induced Allergic Rhinitis
por: Yusin, Joseph, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1s7cb4ld10k447se7l2e78s756